ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	379	424	167	208	265	268
Market Cap Growth	25.51%	153.78%	-19.62%	-21.59%	-1.05%	267.26%
Enterprise Value	380	406	157	179	228	271
Last Close Price	13.74	15.38	6.79	8.47	11.22	15.89
PS Ratio	11.21	13.52	6.98	10.12	16.27	20.90
PB Ratio	24.61	16.71	7.90	5.64	5.44	112.77
P/TBV Ratio	24.12	17.04	8.30	5.80	5.47	132.44
EV/Sales Ratio	11.08	12.95	6.55	8.73	13.97	21.16
Debt / Equity Ratio	2.25	0.14	0.66	0.33	0.25	10.15
Asset Turnover	0.68	0.77	0.49	0.34	0.34	0.62
Inventory Turnover	1.95	1.66	1.20	0.99	1.27	1.15
Quick Ratio	5.40	2.46	3.65	5.92	11.88	6.87
Current Ratio	6.37	3.22	4.87	7.54	13.02	7.96
Return on Equity (ROE)	-103.13%	-81.24%	-76.09%	-38.37%	-56.33%	-194.80%
Return on Assets (ROA)	-28.30%	-30.16%	-28.59%	-16.86%	-17.58%	-18.76%
Return on Capital (ROIC)	-33.75%	-38.52%	-33.41%	-18.57%	-19.09%	-23.18%
Return on Capital Employed (ROCE)	-43.50%	-68.50%	-63.70%	-33.50%	-22.00%	-23.60%
Earnings Yield	-6.04%	-4.46%	-13.21%	-7.90%	-5.43%	-2.53%
FCF Yield	-3.61%	-2.17%	-8.64%	-7.90%	-4.85%	-2.93%
Buyback Yield / Dilution	-6.52%	-9.84%	-1.75%	-16.63%	-30.82%	-20.48%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q